XTANT Medical

Belgrade, United States Founded: 2006 • Age: 20 yrs Listed
Orthobiologic products and spinal fixation systems are developed and commercialized.

About XTANT Medical

XTANT Medical is a publicly listed company based in Belgrade (United States) founded in 2006. Orthobiologic products and spinal fixation systems are developed and commercialized. XTANT Medical has raised $10.98 million across 16 funding rounds from investors including Orbimed, Stavros Vizirgianakis and Military Health. The company has 232 employees. XTANT Medical has completed 2 acquisitions, including Coflex Solution and Xtant Medical. Its website xtantmedical.com draws about 11 thousand monthly visits. XTANT Medical offers products and services including Orthobiologics and Spinal Fixation Systems. Its focus areas include Medical Device Outsourcing.

Company details

XTANT Medical was founded in 2006 in Belgrade, United States, within the medical devices sector. A range of orthobiologic products and spinal implant systems is designed, developed, and commercialized for surgical applications. Orthobiologics are processed in an advanced tissue facility, while spinal systems address cervical, thoraco-lumbar, and interbody needs. Operations emphasize the provision of human tissues and implants for patient procedures across various specialties.

  • Headquarters Belgrade, United States
  • Employees 232
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website xtantmedical.com
  • Social LinkedIn
  • Legal Name Xtant Medical Holdings, Inc.
Key Metrics
  • Annual Revenue
    $133.93 M (USD)
    14.21
    as on Dec 31, 2025
  • Net Profit
    $4.97 M (USD)
    as on Dec 31, 2025
  • EBITDA
    $12.51 M (USD)
    as on Dec 31, 2025
  • Total Equity Funding
    $10.98M (USD)

    in 16 rounds

  • Latest Funding Round
    $5M (USD), Post-IPO

    Aug 2024

  • Investors
    Orbimed

    & 2 more

  • Employee Count
    232
  • Investments & Acquisitions

Products & Services of XTANT Medical

XTANT Medical offers a comprehensive portfolio of products and services, including Orthobiologics and Spinal Fixation Systems.

Orthobiologics
Medical Products

A comprehensive portfolio of orthobiologic products is designed and manufactured in state-of-the-art tissue processing facilities for various medical applications

Spinal Fixation Systems
Medical Devices

Systems for cervical, thoraco-lumbar, and interbody spinal implants are utilized in complex, deformity, and degenerative procedures

Funding Insights of XTANT Medical

XTANT Medical has successfully raised a total of $10.98M across 16 strategic funding rounds. The most recent funding activity was a Post-IPO round of $5 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $10.98M
  • Total Rounds 16
  • Last Round Post-IPO β€” $5M
  • First Round $3.48M

    (Mar 2010)

  • Investors Count 3

Latest 10 of 16 funding rounds of XTANT Medical with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Aug 2024$5MPost-IPO––
–
Jul 2023$15MPost-IPO––
–
Aug 2022Post-IPO––
Feb 2021$20MPost-IPO––
–
Oct 2020$62.88MPost-IPO––
–
Feb 2018$70.24MPost-IPO––
Jul 2015$68MPost-IPO––
–
Mar 2014$4MDebt – Conventional––
–
Jun 2013$4.85MPost-IPO––
–
Jul 2012$20MDebt – Conventional––
–
Valuation history

3 investors in total: 2 institutional and 1 angel.

Investors in XTANT Medical

XTANT Medical has secured backing from 3 investors, including angel, venture fund, and institutional investors. Prominent investors backing the company include Orbimed, Stavros Vizirgianakis and Military Health.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
1989orbimed.comNew York, United States
Administers health care and support for military personnel and operations.
health.milFalls Church, United States

Stavros Vizirgianakis

unknown_d8ae78a7e8db471da
Premium access

Investor details for XTANT Medical

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

IPO & Listings of XTANT Medical

XTANT Medical is a publicly listed company on the AMEX with ticker symbol XTNT in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date07 Mar 2011
  • Listed onNYSE: BONE
  • Listed entityXtant Medical Holdings, Inc.
  • Exchange sectorHealth technology
  • ISINUS98420P3082
  • Share price$0.32 (-1.43% on the day) · 2026-10-13
  • Market capitalisation$45.5M
  • Price to earnings72.5
  • EPS (diluted, trailing year)$-0.08
  • Volume (last session)38,410

Financials of XTANT Medical

Exchange-reported annual figures
YearRevenueNet incomeEBITDA
2025$133.9M$5.0M$12.5M
2024$117.3M-$16.4M-$7.8M
2023$91.3M$660,000-$7.0M
2022$58.0M-$8.5M-$5.5M
2021$55.3M-$4.8M-$2.5M
Premium access

Detailed financial statements for XTANT Medical

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by XTANT Medical

XTANT Medical has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Coflex Solution and Xtant Medical.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Lumbar motion preservation implants are manufactured by Coflex Solution.
coflexsolution.comNew York, United States2013Mar 2023$17M
Implants and regenerative products are developed for orthopedic conditions.
x-spine.comMiamisburg, United States2003Jul 2015$86M
Premium access

Complete acquisition details for XTANT Medical

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of XTANT Medical

6 dated milestones of XTANT Medical across 18 years, from founding to its latest funding, stage changes and deals.

  1. Founded XTANT Medical is founded.
  2. Funding First funding round of $3.5M.
  3. IPO Lists on the stock exchange (IPO).
  4. Acquisition Acquires Xtant Medical.
  5. Acquisition Acquires Coflex Solution.
  6. Funding Latest funding round, Post-IPO, of $5.0M.

Web traffic of XTANT Medical

The website of XTANT Medical (xtantmedical.com) receives about 10.7K visits a month.

  • Monthly visits
    10.7K

    ▲ 55.2% vs previous month

Similar websites

Websites whose visitors overlap most with XTANT Medical. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
orthospinenews.com
100%
#2,329,807View details

Top companies in Medical Device Tech & Outsourcing

3 companies that operate in the same segment as XTANT Medical (Medical Device Tech & Outsourcing) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Home medical and respiratory equipment and supplies are distributed.
2005Phoenixville, Pennsylvania, United StatesUSD 4 MUSD 3.24 B10,500
Cybersecurity solutions for medical devices are provided by MedCrypt.
2016San Diego, California, United StatesUSD 63.75 M
Laboratory and production supplies and services are provided.
1902Hampton, Virginia, United States592
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Xtant Medical

Premium access

Complete news archive for XTANT Medical

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about XTANT Medical

XTANT Medical was founded in 2006 and raised its 1st funding round 4 years after it was founded.

XTANT Medical is headquartered in Belgrade, United States. It is registered at Belgrade, Montana, United States.

XTANT Medical is a funded company, having raised a total of $10.98M across 16 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $20M, raised on Mar 2010.

XTANT Medical has 232 employees.

Annual revenue of XTANT Medical is $133.93M as on Dec 31, 2025.

XTANT Medical was founded in 2006 in Belgrade, United States, within the medical devices sector. A range of orthobiologic products and spinal implant systems is designed, developed, and commercialized for surgical applications. Orthobiologics are processed in an advanced tissue facility, while spinal systems address cervical, thoraco-lumbar, and interbody needs. Operations emphasize the provision of human tissues and implants for patient procedures across various specialties.

XTANT Medical offers Orthobiologics and Spinal Fixation Systems.

Yes, XTANT Medical is publicly traded on AMEX under the ticker symbol XTNT.

XTANT Medical has made 2 acquisitions, including Coflex Solution, and Xtant Medical.

XTANT Medical has 3 investors. Key investors include Orbimed, Stavros Vizirgianakis, and Military Health.

XTANT Medical operates through Xtant Medical.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available